JDD: Celebrating 10 Years of Publishing Excellence

January 2012 | Volume 11 | Issue 1 | Editorials | 17 | Copyright © 2012

Perry Robins MD

Abstract

No abstract available

Purchase Original Article

Purchase a single fully formatted PDF of the original manuscript as it was published in the JDD.

Download the original manuscript as it was published in the JDD.

Contact a member of the JDD Sales Team to request a quote or purchase bulk reprints, e-prints or international translation requests.

To get access to JDD's full-text articles and archives, upgrade here.

Save an unformatted copy of this article for on-screen viewing.

Print the full-text of article as it appears on the JDD site.

→ proceed | ↑ close
table 1

Throughout my professional life, I have been extremely fortunate. Having lectured in many parts of the country and abroad, I have listened to many people comment on the long turn-around time of journals such as the Journal of the American Academy of Dermatology and Archives of Dermatology, with some taking as long as one year for publication of submitted materials that are novel to the field of dermatology. Taking into account this pressing need to bring relevant dermatologic knowledge to the community faster, we launched the first issue of the Journal of Drugs in Dermatology in July 2002 with the generous support of the pharmaceutical industry and many colleagues in the U.S. and abroad.

The first year, which comprised six issues, was remarkably successful. In 2006, we converted from six to 10 issues per year, and, in 2007, to 12 issues. Each year, the number of submitted manuscripts of outstanding quality increased substantially, allowing us to also increase the number of manuscripts printed in each issue. With new features such as Resident Rounds, Clinical Trial Review, News Views & Reviews, Pipeline Previews, and now, Surgical Corner, we've expanded JDD's reach to dermatology residency programs in the country, as well as monthly providing dermatologists with valuable information on current clinical trials and focused updates on the latest developments in dermatologic therapy and techniques. Additionally, we also began releasing several supplements to the Journal per year, bringing valuable and timely information to the dermatological community.

We are proud to have been indexed in MEDLINE®/PubMed® from Volume 1, Issue 1, and our newly received impact factor, 1.954, is most respectable for a journal that is only now approaching its 10th year. Each year, not only do we continue to attract outstanding manuscripts from dermatologists from this country, but we see an increase in the number of manuscripts submitted by international authors as well. Via JDDonline.com, the Journal of Drugs in Dermatology has proudly provided worldwide access to its content to readers abroad, as well as establishing partnerships with 21 international societies. The distribution of eJDD to 50,000 dermatologists across the globe was a groundbreaking achievement. The Journal aims to double this number within the next six months, which will no doubt give it the largest distribution of any journal being published in the field today.

As Editor-in-Chief of JDD, I have no doubt that the numbers above will only improve in the coming years, as the Journal has already firmly established itself as an indispensable publication in the field. This is the first of a series of editorials chronicling JDD's remarkable achievements since its inception in 2002, and I hope you will join us in celebrating as my colleagues share their own experiences with JDD in each upcoming issue of 2012.

Perry Robins MD
Editor-in-Chief

table 1

↑ back to top


  • 1

Related Articles